Skip to main content

Table 2 Gene ontologies: Molecular functions of differentially expressed genes

From: Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis

ID

Name

p-value

q-value, Bonferroni

q-value, FDR B&H

q-value, FDR B&Y

Hit Count in Query List

Hit Count in Genome

Hit in Query List

GO:0038187

pattern recognition receptor activity

5.52E− 07

3.76E− 04

1.88E− 04

1.34E− 03

5

17

CLEC7A, LY96, PTAFR, CD14, TLR2

GO:0008329

signaling pattern recognition receptor activity

5.52E−07

3.76E−04

1.88E− 04

1.34E−03

5

17

CLEC7A, LY96, PTAFR, CD14, TLR2

GO:0001875

lipopolysaccharide receptor activity

9.92E−06

6.75E−03

2.25E− 03

1.60E− 02

3

5

LY96, PTAFR, TLR2

GO:0042497

triacyl lipopeptide binding

1.02E−04

6.95E− 02

1.39E− 02

9.87E− 02

2

2

TLR1, TLR2

GO:0016230

sphingomyelin phosphodiesterase activator activity

1.02E−04

6.95E−02

1.39E− 02

9.87E− 02

2

2

STX4, NSMAF

GO:0042277

peptide binding

1.24E−04

8.44E−02

1.41E− 02

9.99E− 02

11

278

HLA-B, HLA-E, FFAR4, NFKBIA, TAP1, NUP98, PPIF, FURIN, TLR1, TLR2, SLC7A5

GO:0016004

phospholipase activator activity

2.07E−04

1.41E−01

1.92E−02

1.36E−01

3

12

STX4, CCL3, NSMAF

GO:0042287

MHC protein binding

2.54E−04

1.73E−01

1.92E−02

1.36E−01

4

31

LILRB2, HLA-E, CLEC7A, TAP1

GO:0042605

peptide antigen binding

2.88E−04

1.96E−01

1.92E−02

1.36E−01

4

32

HLA-B, HLA-E, TAP1, SLC7A5

GO:0033218

amide binding

3.09E−04

2.11E−01

1.92E−02

1.36E−01

11

309

HLA-B, HLA-E, FFAR4, NFKBIA, TAP1, NUP98, PPIF, FURIN, TLR1, TLR2, SLC7A5

GO:0005102

receptor binding

3.11E−04

2.12E−01

1.92E−02

1.36E−01

31

1601

RELN, HLA-B, LILRB2, HLA-E, ETS2, CLEC7A, LRG1, ADM, CMTM6, TYROBP, TMC8, CCL3, CCL4, FGR, TAP1, PLSCR1, NSMAF, SECTM1, PROK2, SELPLG, ICAM1, CCL3L3, SH2B2, NAMPT, GNA13, TNFSF13B, TLR1, TLR2, IRS2, LYN, IL1RN

GO:0060229

lipase activator activity

3.38E−04

2.30E−01

1.92E−02

1.36E−01

3

14

STX4, CCL3, NSMAF

GO:0019899

enzyme binding

4.15E−04

2.83E−01

2.17E−02

1.54E−01

35

1929

LILRB2, RNF19B, TNFRSF14, GBP1, PTAFR, CKB, SERPINB9, STX4, FGD4, CXCR4, XPO6, PLIN5, NFKBIA, EHD1, FGR, PLEK, NOS1, PLSCR1, ALOX5AP, SELL, RICTOR, LCP1, SH2B2, ZFP36, RHOH, LMNB1, FURIN, PPP1R18, IRS2, TNFAIP3, TNFRSF1B, LYN, TRIB1, MARCKS, SOD2

GO:0023029

MHC class Ib protein binding

5.98E−04

4.07E−01

2.91E−02

2.07E−01

2

4

LILRB2, TAP1

GO:0070891

lipoteichoic acid binding

9.90E−04

6.74E−01

4.49E−02

3.19E−01

2

5

CD14, TLR2

GO:0042288

MHC class I protein binding

1.17E−03

7.97E−01

4.74E−02

3.37E−01

3

21

LILRB2, HLA-E, TAP1

GO:0042802

identical protein binding

1.18E−03

8.07E−01

4.74E−02

3.37E−01

26

1359

CEBPD, DDX58, B2M, GBP1, BCL2A1, TYROBP, BNIP3L, GBP5, DGAT2, PLIN5, NFKBIA, GLUL, GCA, CCL3, CCL4, PLEK, NOS1, TAP1, ALOX5AP, RILPL2, LCP1, SH2B2, IFIT3, NAMPT, FTL, SOD2